Market Overview The global healthcare bio convergence market was valued at USD 121.50 billion in 2022 and is expected to grow at a CAGR of 7.5% during the forecast period. The healthcare bioconvergence market is experiencing significant expansion, This growth is fueled by increasing demand for personalized medicine, advancements in AI and machine learning, and the integration of digital...